297 related articles for article (PubMed ID: 15940634)
1. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Targan SR; Landers CJ; Yang H; Lodes MJ; Cong Y; Papadakis KA; Vasiliauskas E; Elson CO; Hershberg RM
Gastroenterology; 2005 Jun; 128(7):2020-8. PubMed ID: 15940634
[TBL] [Abstract][Full Text] [Related]
2. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
[TBL] [Abstract][Full Text] [Related]
3. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
[TBL] [Abstract][Full Text] [Related]
4. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.
Dubinsky MC; Lin YC; Dutridge D; Picornell Y; Landers CJ; Farrior S; Wrobel I; Quiros A; Vasiliauskas EA; Grill B; Israel D; Bahar R; Christie D; Wahbeh G; Silber G; Dallazadeh S; Shah P; Thomas D; Kelts D; Hershberg RM; Elson CO; Targan SR; Taylor KD; Rotter JI; Yang H;
Am J Gastroenterol; 2006 Feb; 101(2):360-7. PubMed ID: 16454844
[TBL] [Abstract][Full Text] [Related]
5. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis.
Fleshner P; Ippoliti A; Dubinsky M; Vasiliauskas E; Mei L; Papadakis KA; Rotter JI; Landers C; Targan S
Clin Gastroenterol Hepatol; 2008 May; 6(5):561-8. PubMed ID: 18378498
[TBL] [Abstract][Full Text] [Related]
6. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
[TBL] [Abstract][Full Text] [Related]
7. Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
Alexander KL; Zhao Q; Reif M; Rosenberg AF; Mannon PJ; Duck LW; Elson CO
Gastroenterology; 2021 Aug; 161(2):522-535.e6. PubMed ID: 33844987
[TBL] [Abstract][Full Text] [Related]
8. Serum antibodies associated with complex inflammatory bowel disease.
Elkadri AA; Stempak JM; Walters TD; Lal S; Griffiths AM; Steinhart AH; Silverberg MS
Inflamm Bowel Dis; 2013 Jun; 19(7):1499-505. PubMed ID: 23702714
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study.
Wallis D; Asaduzzaman A; Weisman M; Haroon N; Anton A; McGovern D; Targan S; Inman R
Arthritis Res Ther; 2013 Oct; 15(5):R166. PubMed ID: 24286190
[TBL] [Abstract][Full Text] [Related]
10. Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype.
Wang ZZ; Shi K; Peng J
Biomed Rep; 2017 Apr; 6(4):401-410. PubMed ID: 28413638
[TBL] [Abstract][Full Text] [Related]
11. Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.
Spencer EA; Davis SM; Mack DR; Boyle BM; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz JF; Baker SS; Rosh JR; Baldassano RN; Oliva-Hemker M; Pfefferkorn MD; Otley AR; Heyman MB; Noe JD; Patel AS; Rufo PA; ; Alison Marquis M; Walters TD; Collins MH; Kugathasan S; Denson LA; Hyams JS; Dubinsky MC
Inflamm Bowel Dis; 2018 May; 24(6):1335-1343. PubMed ID: 29718391
[TBL] [Abstract][Full Text] [Related]
12. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
13. Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease.
Shen C; Landers CJ; Derkowski C; Elson CO; Targan SR
Inflamm Bowel Dis; 2008 Dec; 14(12):1641-51. PubMed ID: 18825772
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
[TBL] [Abstract][Full Text] [Related]
15. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?
Markowitz J; Kugathasan S; Dubinsky M; Mei L; Crandall W; LeLeiko N; Oliva-Hemker M; Rosh J; Evans J; Mack D; Otley A; Pfefferkorn M; Bahar R; Vasiliauskas E; Wahbeh G; Silber G; Quiros JA; Wrobel I; Nebel J; Landers C; Picornell Y; Targan S; Lerer T; Hyams J
Inflamm Bowel Dis; 2009 May; 15(5):714-9. PubMed ID: 19107777
[TBL] [Abstract][Full Text] [Related]
16. Serological markers predict inflammatory bowel disease years before the diagnosis.
van Schaik FD; Oldenburg B; Hart AR; Siersema PD; Lindgren S; Grip O; Teucher B; Kaaks R; Bergmann MM; Boeing H; Carbonnel F; Jantchou P; Boutron-Ruault MC; Tjønneland A; Olsen A; Crowe FL; Peeters PH; van Oijen MG; Bueno-de-Mesquita HB
Gut; 2013 May; 62(5):683-8. PubMed ID: 22842615
[TBL] [Abstract][Full Text] [Related]
17. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
Landers CJ; Cohavy O; Misra R; Yang H; Lin YC; Braun J; Targan SR
Gastroenterology; 2002 Sep; 123(3):689-99. PubMed ID: 12198693
[TBL] [Abstract][Full Text] [Related]
18. Increased immune reactivity predicts aggressive complicating Crohn's disease in children.
Dubinsky MC; Kugathasan S; Mei L; Picornell Y; Nebel J; Wrobel I; Quiros A; Silber G; Wahbeh G; Katzir L; Vasiliauskas E; Bahar R; Otley A; Mack D; Evans J; Rosh J; Hemker MO; Leleiko N; Crandall W; Langton C; Landers C; Taylor KD; Targan SR; Rotter JI; Markowitz J; Hyams J; ; ;
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1105-11. PubMed ID: 18619921
[TBL] [Abstract][Full Text] [Related]
19. Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.
Takedatsu H; Taylor KD; Mei L; McGovern DP; Landers CJ; Gonsky R; Cong Y; Vasiliauskas EA; Ippoliti A; Elson CO; Rotter JI; Targan SR
Gut; 2009 Jan; 58(1):60-7. PubMed ID: 18832525
[TBL] [Abstract][Full Text] [Related]
20. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
